Method of isolating CD8+ cells, and related hybridoma cells, antibodies and polypeptides

Details for Australian Patent Application No. 2005209613 (hide)

Owner Ortho-McNeil Pharmaceutical, Inc.

Inventors Leturcq, Didier J.

Agent Shelston IP

Pub. Number AU-B-2005209613

Parent 37284

Filing date 8 September 2005

Wipo publication date 6 October 2005

Acceptance publication date 12 July 2007

International Classifications

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/08 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 5/20 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

22 September 2005 Complete Application Filed

6 October 2005 Application Open to Public Inspection

  Published as AU-B-2005209613

12 July 2007 Application Accepted

  Published as AU-B-2005209613

8 November 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005209615-Gaming device having a free spin game

2005209612-Special purpose paint roller & tray